Factors significantly associated with an increased risk of meeting the primary endpoint included male sex, diabetes, reduced renal function (eGFR < 60 mL/min/1.73 m2), and receiving non-statin lipid-lowering treatment, aspirin or P2Y12 inhibitors, beta-blockers, or RAAS inhibitors. Here, P2RY12 is linked to diabetes mellitus.